Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Sandra Nabachwa"'
Autor:
Deven Patel, Davide Bilardi, Carlo Giaquinto, Andrea Atzori, Antonio Mazza, Maria Nannyonga, William Massavon, Maria L. Mastrogiacomo, Martina Penazzato, Erika Morelli, Giovanni Putoto, Genny Franceschetto, Sandra Nabachwa, Giuliana Rossi, Paola Costenaro, Rebecca Lundin
Publikováno v:
Journal of the Pediatric Infectious Diseases Society. 4:39-48
Background. Delays detecting treatment failure and switching to second-line combination antiretroviral therapy (cART) are often observed in human immunodeficiency virus (HIV)–infected children of low-middleincome countries (LMIC). Methods. An obser
Autor:
Carlo Giaquinto, Rebecca Lundin, Sandra Nabachwa, Paola Costenaro, Charles Namisi, Davide Bilardi, William Massavon, Susan Kizito, Martina Penazzato, Mark F. Cotton, Agnes Alowo, Federica Fregonese, Maria Nannyonga Musoke, Erika Morelli, Antonio Mazza
Publikováno v:
Journal of acquired immune deficiency syndromes (1999). 71(1)
Background Intensified tuberculosis (TB) case finding and isoniazid preventive therapy (IPT) are strongly recommended for children who are HIV infected. Data are needed to assess the feasibility of the WHO 2011 intensified tuberculosis case finding/I
Autor:
Rebecca Lundin, William Massavon, Carlo Giaquinto, Anita De Rossi, Martina Penazzato, Antonio Mazza, Susan Kizito, Marisa Zanchetta, Erika Morelli, Maria Nannyonga Musoke, Charles Namisi, Maria Raffaella Petrara, Sandra Nabachwa, Paola Costenaro, Davide Bilardi
Publikováno v:
Journal of Clinical Microbiology. 52:2665-2667
Correlations between clinical/immunological treatment failure and viral load (VL) detected by dried blood spot (DBS) sampling were explored in HIV-1-infected children in Uganda. Of 104 children on combined antiretroviral treatment (cART), 12.5% exper
Autor:
Rebecca Lundin, Carlo Giaquinto, Anita De Rossi, Ketty Gianesin, William Massavon, Martina Penazzato, Paola Del Bianco, Antonio Mazza, Maria Nannyonga, Colin Sumpter, Maria Raffaella Petrara, Marisa Zanchetta, Sandra Nabachwa
Background. Epstein-Barr Virus (EBV) is involved in a wide range of malignancies, particularly in immunocompromised subjects. In Africa, EBV primary infection occurs during early childhood, but little is known about the EBV load in Human Immunodefici
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2891d94968ce4eaa03553bc659d01fba
http://hdl.handle.net/11577/2798884
http://hdl.handle.net/11577/2798884